Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3917 results

Sort By:

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Study ID: NCT07071623
Start Date: 2025-10-31
End Date: 2028-01-14
Study Type

Interventional

Study Phase

Phase3

No. of Participants

4580

Intervention / Treatment

MK-8527

Emtricitabine/tenofovir disoproxil (FTC/TDF)

Placebo matched to MK-8527

Placebo matched to FTC/TDF

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

SAFEGUARD Life Force Study

Study ID: NCT07050238
Start Date: 2025-08-15
End Date: 2029-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

2400

Intervention / Treatment

The Life Force program

Sponsor

Uniformed Services University of the Health Sciences

Source: clinicaltrials.gov

Share:
Add to list

Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

Study ID: NCT06926595
Start Date: 2025-08-01
End Date: 2031-08-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

41

Intervention / Treatment

Cyclophosphamide (primary intervention for GVHD prophylaxis)

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Assessing Perceptual Effects of Interactive Tasks

Study ID: NCT06828523
Start Date: 2027-10-01
End Date: 2029-02-28
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1300

Intervention / Treatment

Listener judgements of speech produced in different tasks

Sponsor

Penn State University

Source: clinicaltrials.gov

Share:
Add to list

Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris

Study ID: NCT06729450
Start Date: 2026-01-30
End Date: 2026-12-16
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24

Intervention / Treatment

DispersinB Acne Cleanser

Sponsor

Kane Biotech Inc

Source: clinicaltrials.gov

Share:
Add to list

Attitudes and Perceptions Attitudes and Smoking Perceptions in the Real Environment -II

Study ID: NCT06668350
Start Date: 2025-08
End Date: 2029-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

190

Intervention / Treatment

Smoking outcomes

Sponsor

University of Oklahoma

Source: clinicaltrials.gov

Share:
Add to list

Digoxin Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients

Study ID: NCT07025850
Start Date: 2025-08-01
End Date: 2027-05-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Digoxin

Fuquinitinib

Tiskelizumab

Sponsor

Fudan University

Source: clinicaltrials.gov

Share:
Add to list

BiOfeedback, Online for Sibilant Treatment

Study ID: NCT07041723
Start Date: 2025-08-01
End Date: 2027-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6

Intervention / Treatment

Visual-acoustic biofeedback for Sibilants

Sponsor

Montclair State University

Source: clinicaltrials.gov

Share:
Add to list

Experiment Among Smokers in Which Two Variables Are Manipulated: Ostracism and Concealability

Study ID: NCT06462950
Start Date: 2028-05
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

340

Intervention / Treatment

Do men and women differ in their reactions to the experimental conditions.

Sponsor

Dickinson College

Source: clinicaltrials.gov

Share:
Add to list

The Volunteering-in-Place Program for Apathetic Assisted Living Residents With ADRD

Study ID: NCT06735950
Start Date: 2025-09
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Volunteering in Place Program

Recreational activity

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list